Promoter Group Acquires Additional Stake in Indoco Remedies Limited
Indoco Remedies Ltd · Acquisition/ Disposal of Shares · 13 Nov 2026, 4:31 pm
Promoter Group Acquires Additional Stake in Indoco Remedies Limited Promoter group members of Indoco Remedies Limited—Aditi M. Panandikar, Madhura Suresh Kare, Suresh G Kare, and Aruna Suresh Kare—acquired 5,225 equity shares (0.006% stake) via open market purchases on 11th Nov'26 and 12th Nov'26. Following this transaction, the collective holding of the promoter and PACs increased from 67,78,617 shares (7.343%) to 67,83,842 shares (7.348% of total voting capital). The company's total equity share capital remains unchanged at Rs. 18.46 crore, comprising 9,23,18,455 equity shares of Rs. 2 each.
Original exchange filing (PDF)
More announcements from Indoco Remedies Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Suresh G Kare · 09 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Suresh G Kare · 07 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others · 06 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ms. Aditi M Panandikar & Ms. Madhura Suresh Kare · 04 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others · 03 Nov 2026
- Transcript of Earnings Conference Call on Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30-09-2026 · 29 Oct 2026
- Audio recording of Earnings Conference Call on Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended 30th September, 2026 · 27 Oct 2026
- Indoco''s Clinical Research Orgainsation - AnaCipher receives approval from ANVISA Brazil for its clinical and bioanalytical facilities · 27 Oct 2026
